Showing results (61-70 of 138) with videos related to
Sort By:
Pageof 14
Cancer Research|October 3, 2007
Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex virusesSusan Varghese, Samuel D Rabkin, G Petur Nielsen, et al.Cancer Cell International|November 1, 2014
Treatment of human hepatocellular carcinoma by the oncolytic herpes simplex virus G47deltaJiani Wang, Lihua Xu, Weigen Zeng, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 1, 2025
Understanding the interplay between oHSV and the host immune system: Implications for therapeutic oncolytic virus developmentKalkidan Ayele, Hiroaki Wakimoto, Hans J Nauwynck, et al.The Journal of General Virology|August 16, 2005
Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunityHenning Lauterbach, Christine Ried, Alberto L Epstein, et al.Human Vaccines|May 24, 2008
HSV as a vector in vaccine development and gene therapyPeggy Marconi, Rafaela Argnani, Elena Berto, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2018
Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell ModelsDipongkor Saha, Hiroaki Wakimoto, Cole W Peters, et al.Journal for Immunotherapy of Cancer|April 10, 2024
Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survivalPraveen K Bommareddy, Hiroaki Wakimoto, Robert L Martuza, et al.Journal of Virology|September 29, 2004
Herpes simplex virus type 1 ICP0 protein mediates activation of adeno-associated virus type 2 rep gene expression from a latent integrated formMarie-Claude Geoffroy, Alberto L Epstein, Estelle Toublanc, et al.Journal of Virology|February 21, 2012
Effect of γ34.5 deletions on oncolytic herpes simplex virus activity in brain tumorsRyuichi Kanai, Cecile Zaupa, Donatella Sgubin, et al.Asian Pacific Journal of Cancer Prevention : APJCP|March 5, 2015
Treatment of human thyroid carcinoma cells with the g47delta oncolytic herpes simplex virusJia-Ni Wang, Li-Hua Xu, Wei-Gen Zeng, et al.Pageof 14